130 results
Page 5 of 7
F-4
vhccl 1ehvzugdmereq3
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
5pqzyb
7 Jun 21
Prospectus supplement
9:16am
424B3
5zuupfvwqnk
7 Jun 21
Prospectus supplement
9:16am
6-K
EX-99.1
re4myt zt75nr
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
424B3
w5eji1
3 Jun 21
Prospectus supplement
6:06am
424B3
i5u ecwaq7m5fmz337
3 Jun 21
Prospectus supplement
6:06am
6-K
EX-99.1
3vxyipmwyscn 0i
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
ihjqgj
2 Jun 21
Prospectus supplement
10:10am
424B3
87z u7g1x
2 Jun 21
Prospectus supplement
10:09am
424B3
1nfmlv
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
pfezqqm2kr
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
nn0m7 ace7s3
5 May 21
Business combination disclosure
5:27pm
425
pxgdalecdt4 conj3niw
5 May 21
Business combination disclosure
5:26pm
425
c5rsmts ltvxstz52n
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
4zkot
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
ezura3uiv3 856csyvuj
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
jei0kdj4k q43g
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
8v1 gdhx3ubei4
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
w7kv6u2gngxu
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
qvyofrj
30 Apr 21
Annual report (foreign)
12:53pm